BTG3 and systemic sclerosis: The assessment of antinuclear (ANA) and anticytoplasmic autoantibodies using the HEp-2 IFA experiment was a key focus of our study, given the well-established role of autoantibodies in systemic sclerosis (SSc) pathogenesis.